The pediatric asthma treatment market is expected to grow at a CAGR of 3% during the forecast period of 2023 to 2031. Increases in environmental irritants and awareness of the severity of pediatric asthma contribute to the expansion of the global pediatric asthma treatment market. Several pharmaceutical companies are obtaining FDA approval for asthma medications for children. Through digital platforms, leading companies are organizing educational programs for children and healthcare professionals regarding the proper use of inhalers. Increased participation by several large organizations in disseminating information about disease control measures and available asthma treatments is boosting market statistics.
During the forecast period, the market for pediatric asthma treatments in Asia Pacific is anticipated to expand at a rapid rate. According to a study published in the Lung India journal, India is home to at least one in ten asthma patients worldwide, with an estimated 1.5 to 2 billion asthma patients. In addition, up to 40.0% of children are diagnosed with asthma at some point. Increased emphasis on respiratory disease management and awareness of pediatric asthma management are driving market growth in the region.
ECU Health, AstraZeneca PLC, GlaxoSmithKline, CHIESI Farmaceutici S.p.A., Pfizer Inc., Sanofi, Novartis AG, OPKO Health, Inc., Boehringer Ingelheim International GmbH, and Teva Pharmaceutical Industries Ltd. are the leading companies in the pediatric asthma treatment market.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
Increase in Pediatric Asthma Prevalence
In recent decades, the prevalence of pediatric asthma has increased globally, making it a significant public health concern. To prevent long-term complications in children with asthma, early diagnosis, and treatment are essential. According to the Australian Institute of Health and Welfare, approximately 10% of children aged 0 to 14 years in the country suffered from asthma in 2017 and 2018. According to the World Health Organization (WHO), asthma affected approximately 262 million people worldwide in 2019 and caused 4,555,000 deaths. Shortly, the rise in the global prevalence of pediatric asthma is expected to increase the demand for pediatric asthma treatment. The National Asthma Control Program of the CDC and asthma camps conducted by the Asthma Society of India provide asthma patients with effective disease management techniques that improve their quality of life.Environmental Irritants Will Drive the Market for Paediatric Asthma Treatments
Smoke and air pollution are environmental irritants that can trigger asthma symptoms in children. Smoke from cigarettes, wood-burning stoves, and fireplaces may contain irritants that aggravate asthma symptoms by inflaming the airways. Similarly, air pollution and industrial emissions can exacerbate the symptoms of asthma in children. To minimize exposure to these triggers, it is recommended to refrain from smoking indoors, spend less time in highly polluted areas, and utilize air purifiers. Additionally, it is essential to collaborate with pediatricians to develop a comprehensive asthma management plan to reduce the frequency and severity of symptoms.Increased Awareness of the Advantages of Long-Term Control Medication
The global pediatric asthma treatment market is segmented by drug type into long-term control medications and quick-relief medications. In 2022, the segment of long-term control medications dominated the global market. Due to their numerous advantages, long-term control medications, such as combination inhalers, are gaining popularity. Inhalers containing both a corticosteroid and a bronchodilator are known as combination inhalers. They are more effective at reducing asthma symptoms than either medication alone.Increased Demand for Inhalers Augmenting Market Progress
The global pediatric asthma treatment market is segmented by form into inhalers, solutions, pills, and injections. In 2022, the inhalation/inhaler segment held the largest share of the global market. Inhalers can be an effective method for managing asthma symptoms. However, it is essential to employ them properly. Inhalers can effectively and efficiently administer medication. They are additionally portable and compact. This is anticipated to stimulate segment expansion.Increase in Retail Pharmacy Preference for Pediatric Asthma Medications
The market is segmented by distribution channel into hospital pharmacies, retail pharmacies, and online pharmacies. Shortly, the retail pharmacies market segment will likely dominate the industry. People prefer retail pharmacies to purchase pediatric asthma medications due to their convenience.North America Dominates the Global Leader
During the forecast period, North America is anticipated to dominate the global scene. Due to the high prevalence of pediatric asthma in North America, the market in that region is expected to expand at a rapid rate during the forecast period. According to the Centres for Disease Control and Prevention (CDC), approximately 6 million American children aged 0 to 17 suffer from asthma. In light of the region's high prevalence of childhood asthma, several companies are developing innovative treatment procedures. This contributes to the expansion of the pediatric asthma treatment market in North America.During the forecast period, the market for pediatric asthma treatments in Asia Pacific is anticipated to expand at a rapid rate. According to a study published in the Lung India journal, India is home to at least one in ten asthma patients worldwide, with an estimated 1.5 to 2 billion asthma patients. In addition, up to 40.0% of children are diagnosed with asthma at some point. Increased emphasis on respiratory disease management and awareness of pediatric asthma management are driving market growth in the region.
Market Competition to Intensify During the Forecast Period
The global market for pediatric asthma treatment is fragmented, with a large number of local and international players. Expansion of product portfolio and mergers & acquisitions are the primary strategies employed by the most successful businesses.ECU Health, AstraZeneca PLC, GlaxoSmithKline, CHIESI Farmaceutici S.p.A., Pfizer Inc., Sanofi, Novartis AG, OPKO Health, Inc., Boehringer Ingelheim International GmbH, and Teva Pharmaceutical Industries Ltd. are the leading companies in the pediatric asthma treatment market.
- In 2022, the European Medicines Agency approved Sanofi's Dupixent as an adjunctive maintenance therapy for children (6 to 11 years old) with severe asthma and type 2 inflammation.
- GSK announced in September 2019 that the FDA has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin (IL)-5, for the treatment of severe eosinophilic asthma in children aged six and older.
- In the report on the pediatric asthma treatment market, each of these participants is profiled based on parameters including financial overview, business segments, company overview, recent developments, product portfolio, and business strategies.
Historical & Forecast Period
This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of the Pediatric Asthma Treatment market is as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- A number of end users and consumption volume, price, and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Pediatric Asthma Treatment market and their expected impact during the forecast period.
Market Segmentation
Drug Type
- Long-term Control Medications
- Corticosteroids
- Leukotriene Modifiers
- Combination Inhalers
- Theophylline
- Others
- Quick-relief Medications
- Short-acting Beta Agonists
- Others
Form
- Inhalation/Inhalers
- Metered-dose Inhalers
- Dry Powder Inhalers
- Solutions
- Pills
- Injections
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of the Pediatric Asthma Treatment market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Pediatric Asthma Treatment market?
- Which is the largest regional market for Pediatric Asthma Treatment market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving the Pediatric Asthma Treatment market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Pediatric Asthma Treatment market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Pediatric Asthma Treatment Market
2.2. Global Pediatric Asthma Treatment Market, By Drug Type, 2022 (US$ Million)
2.3. Global Pediatric Asthma Treatment Market, By Form, 2022 (US$ Million)
2.4. Global Pediatric Asthma Treatment Market, By Distribution Channel, 2022 (US$ Million)
2.5. Global Pediatric Asthma Treatment Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022
3. Pediatric Asthma Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Pediatric Asthma Treatment Market Vendors
3.2. Strategies Adopted by Pediatric Asthma Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Pediatric Asthma Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Pediatric Asthma Treatment Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Long-term Control Medications
5.3.1.1. Corticosteroids
5.3.1.2. Leukotriene Modifiers
5.3.1.3. Combination Inhalers
5.3.1.4. Theophylline
5.3.1.5. Others
5.3.2. Quick-relief Medications
5.3.2.1. Short-acting Beta Agonists
5.3.2.2. Others
6. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Inhalation/Inhalers
6.3.1.1. Metered-dose Inhalers
6.3.1.2. Dry Powder Inhalers
6.3.2. Solutions
6.3.3. Pills
6.3.4. Injections
7. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
8. North America Pediatric Asthma Treatment Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
8.3. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
8.4. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
8.5.Pediatric Asthma Treatment Market: By Region, 2021-2031, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
8.5.1.1.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
8.5.1.1.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
8.5.1.2.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
8.5.1.2.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
8.5.1.3.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
8.5.1.3.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
9. UK and European Union Pediatric Asthma Treatment Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
9.3. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
9.4. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
9.5.Pediatric Asthma Treatment Market: By Region, 2021-2031, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
9.5.1.1.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
9.5.1.1.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
9.5.1.2.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
9.5.1.2.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
9.5.1.3.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
9.5.1.3.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
9.5.1.4.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
9.5.1.4.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
9.5.1.5. France
9.5.1.5.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
9.5.1.5.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
9.5.1.5.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
9.5.1.6.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
9.5.1.6.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
10. Asia Pacific Pediatric Asthma Treatment Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
10.3. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
10.4. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
10.5.Pediatric Asthma Treatment Market: By Region, 2021-2031, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
10.5.1.1.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
10.5.1.1.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
10.5.1.2.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
10.5.1.2.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
10.5.1.3. India
10.5.1.3.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
10.5.1.3.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
10.5.1.3.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
10.5.1.4.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
10.5.1.4.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
10.5.1.5.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
10.5.1.5.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
10.5.1.6.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
10.5.1.6.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
11. Latin America Pediatric Asthma Treatment Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
11.3. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
11.4. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
11.5.Pediatric Asthma Treatment Market: By Region, 2021-2031, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
11.5.1.1.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
11.5.1.1.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
11.5.1.2.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
11.5.1.2.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
11.5.1.3.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
11.5.1.3.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
12. Middle East and Africa Pediatric Asthma Treatment Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
12.3. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
12.4. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
12.5.Pediatric Asthma Treatment Market: By Region, 2021-2031, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
12.5.1.1.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
12.5.1.1.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
12.5.1.2.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
12.5.1.2.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Pediatric Asthma Treatment Market: By Drug Type, 2021-2031, USD (Million)
12.5.1.3.1. Pediatric Asthma Treatment Market: By Form, 2021-2031, USD (Million)
12.5.1.3.1. Pediatric Asthma Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
13. Company Profile
13.1. ECU Health
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. AstraZeneca PLC
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. GlaxoSmithKline
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. CHIESI Farmaceutici S.p.A.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Pfizer Inc.
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Sanofi
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Novartis AG
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. OPKO Health, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Boehringer Ingelheim International GmbH
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Teva Pharmaceutical Industries Ltd.
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Others
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
List of Figures
Figure 1 Global Pediatric Asthma Treatment Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Pediatric Asthma Treatment Market: Quality Assurance
Figure 5 Global Pediatric Asthma Treatment Market, By Drug Type, 2022
Figure 6 Global Pediatric Asthma Treatment Market, By Form, 2022
Figure 7 Global Pediatric Asthma Treatment Market, By Distribution Channel, 2022
Figure 8 Global Pediatric Asthma Treatment Market, By Geography, 2022
Figure 9 Market Geographical Opportunity Matrix - Global Pediatric Asthma Treatment Market, 2022
Figure 10 Market Positioning of Key Pediatric Asthma Treatment Market Players, 2022
Figure 11 Global Pediatric Asthma Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 12 Global Pediatric Asthma Treatment Market, By Drug Type, 2022 Vs 2031, %
Figure 13 Global Pediatric Asthma Treatment Market, By Form, 2022 Vs 2031, %
Figure 14 Global Pediatric Asthma Treatment Market, By Distribution Channel, 2022 Vs 2031, %
Figure 15 U.S. Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 16 Canada Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 17 Rest of North America Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 18 UK Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 19 Germany Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 20 Spain Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 21 Italy Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 22 France Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 23 Rest of Europe Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 24 China Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 25 Japan Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 26 India Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 27 Australia Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 28 South Korea Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 29 Rest of Asia Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 30 Brazil Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 31 Mexico Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 32 Rest of Latin America Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 33 GCC Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 34 Africa Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
Figure 35 Rest of Middle East and Africa Pediatric Asthma Treatment Market (US$ Million), 2021 - 2031
List of Figures
Table 1 Global Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 2 Global Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 3 Global Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 4 Global Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 5 Global Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 6 Global Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 7 North America Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 8 North America Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 9 North America Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 10 North America Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 11 North America Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 12 North America Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 13 U.S. Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 14 U.S. Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 15 U.S. Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 16 U.S. Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 17 U.S. Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 18 U.S. Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 19 Canada Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 20 Canada Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 21 Canada Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 22 Canada Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 23 Canada Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 24 Canada Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 25 Rest of North America Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 26 Rest of North America Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 27 Rest of North America Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 28 Rest of North America Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 29 Rest of North America Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 30 Rest of North America Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 31 UK and European Union Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 32 UK and European Union Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 33 UK and European Union Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 34 UK and European Union Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 35 UK and European Union Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 36 UK and European Union Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 37 UK Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 38 UK Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 39 UK Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 40 UK Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 41 UK Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 42 UK Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 43 Germany Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 44 Germany Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 45 Germany Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 46 Germany Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 47 Germany Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 48 Germany Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 49 Spain Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 50 Spain Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 51 Spain Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 52 Spain Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 53 Spain Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 54 Spain Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 55 Italy Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 56 Italy Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 57 Italy Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 58 Italy Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 59 Italy Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 60 Italy Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 61 France Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 62 France Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 63 France Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 64 France Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 65 France Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 66 France Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 67 Rest of Europe Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 68 Rest of Europe Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 69 Rest of Europe Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 70 Rest of Europe Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 71 Rest of Europe Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 72 Rest of Europe Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 73 Asia Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 74 Asia Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 75 Asia Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 76 Asia Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 77 Asia Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 78 Asia Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 79 China Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 80 China Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 81 China Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 82 China Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 83 China Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 84 China Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 85 Japan Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 86 Japan Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 87 Japan Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 88 Japan Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 89 Japan Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 90 Japan Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 91 India Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 92 India Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 93 India Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 94 India Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 95 India Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 96 India Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 97 Australia Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 98 Australia Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 99 Australia Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 100 Australia Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 101 Australia Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 102 Australia Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 103 South Korea Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 104 South Korea Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 105 South Korea Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 106 South Korea Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 107 South Korea Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 108 South Korea Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 109 Latin America Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 110 Latin America Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 111 Latin America Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 112 Latin America Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 113 Latin America Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 114 Latin America Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 115 Brazil Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 116 Brazil Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 117 Brazil Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 118 Brazil Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 119 Brazil Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 120 Brazil Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 121 Mexico Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 122 Mexico Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 123 Mexico Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 124 Mexico Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 125 Mexico Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 126 Mexico Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 127 Rest of Latin America Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 128 Rest of Latin America Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 129 Rest of Latin America Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 130 Rest of Latin America Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 131 Rest of Latin America Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 132 Rest of Latin America Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 133 Middle East and Africa Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 134 Middle East and Africa Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 135 Middle East and Africa Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 136 Middle East and Africa Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 137 Middle East and Africa Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 138 Middle East and Africa Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 139 GCC Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 140 GCC Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 141 GCC Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 142 GCC Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 143 GCC Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 144 GCC Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 145 Africa Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 146 Africa Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 147 Africa Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 148 Africa Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 149 Africa Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 150 Africa Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Table 151 Rest of Middle East and Africa Pediatric Asthma Treatment Market By Drug Type, 2021-2031, USD (Million)
Table 152 Rest of Middle East and Africa Pediatric Asthma Treatment Market By Long-term Control Medications, 2021-2031, USD (Million)
Table 153 Rest of Middle East and Africa Pediatric Asthma Treatment Market By Quick-relief Medications, 2021-2031, USD (Million)
Table 154 Rest of Middle East and Africa Pediatric Asthma Treatment Market By Form, 2021-2031, USD (Million)
Table 155 Rest of Middle East and Africa Pediatric Asthma Treatment Market By Inhalation/Inhalers, 2021-2031, USD (Million)
Table 156 Rest of Middle East and Africa Pediatric Asthma Treatment Market By Distribution Channel, 2021-2031, USD (Million)
Companies Mentioned
- ECU Health
- AstraZeneca PLC
- GlaxoSmithKline
- CHIESI Farmaceutici S.p.A.
- Pfizer Inc.
- Sanofi
- Novartis AG
- OPKO Health Inc.
- Boehringer Ingelheim International GmbH
- Teva Pharmaceutical Industries Ltd.
